API Generation Study 1 (GS1) Data Use Agreement
Anonymized data are requested for scientific investigation, teaching or planning clinical research. The Generation Program team reviews each request, and approved requesters must sign a Data Transfer Agreement, whose terms are not published.
Our reading of the license, not legal advice. Before you use the data, read the original license and confirm that your use is allowed. We take no responsibility for how you use a dataset. Full disclaimer
What you can do
- Not stated
- Not stated
- Not stated
- Not stated
- Not stated
What you can share
- Not stated
- Not stated
- Not stated
What you must do
- Not stated
- Share alike No
- Yes
- Not stated
- Not stated
- Release code No
- Not stated
- Not stated
Limits
- Not stated
- Not stated
Separate commercial license: Not stated No commercial license offer is published.
Datasets under this license
- API Generation Study 1 (GS1)
Brain MRI and amyloid, FDG and tau PET from a prevention trial of the amyloid vaccine CAD106 and the BACE inhibitor umibecestat in cognitively unimpaired people aged 60 to 75 who carry two copies of APOE4, with screening and longitudinal clinical data.